Álvaro
López Janeiro
Colaborador Clínico
University Health Network
Toronto, CanadáPublikationen in Zusammenarbeit mit Forschern von University Health Network (1)
2023
-
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nature Medicine, Vol. 29, Núm. 6, pp. 1370-1378